NCI Study Shows' Weekly Reader' Conveyed Tobacco Industry Message

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

WASHINGTON--A study funded by a $600,000 grant from the National Cancer Institute shows that for a 5-year period the Weekly Reader, a newspaper aimed at schoolchildren, may have had a pro-smoking stance. Since 1991, the weekly has been owned by K-III Holdings, a subsidiary of Kohlberg Kravis Roberts & Co., which until last spring was majority owner of RJR Nabisco, the second largest US tobacco company.

WASHINGTON--A study funded by a $600,000 grant from the NationalCancer Institute shows that for a 5-year period the WeeklyReader, a newspaper aimed at schoolchildren, may have hada pro-smoking stance. Since 1991, the weekly has been owned byK-III Holdings, a subsidiary of Kohlberg Kravis Roberts &Co., which until last spring was majority owner of RJR Nabisco,the second largest US tobacco company.

During the period of study, from 1989 to 1994, 68% of the WeeklyReader's articles on smoking included the tobacco industry'sviews, while only 38% included an antismoking message, the Universityof California, San Francisco, researchers found. In addition,Joe Camel, RJR's cartoon mascot, made an appearance in eight of34 articles studied.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Related Content